Zhengrong Li

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

David M. Brown, Peter A. Campochiaro, Rishi P. Singh et al. · Ophthalmology · 2010 · 1.1K citations

Ocular Disease, Macular Edema, Ophthalmology

Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

Allen C. Ho, Brandon Busbee, Carl D. Regillo et al. · Ophthalmology · 2014 · 577 citations

Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

Brandon Busbee, Allen C. Ho, David M. Brown et al. · Ophthalmology · 2013 · 492 citations · Full text

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions

Jeffrey S. Heier, Peter A. Campochiaro, Linda Yau et al. · Ophthalmology · 2012 · 462 citations

Diabetic Retinopathy, Ocular Disease, Retinal Vein Occlusions +2

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)

Solange Peters, Scott Gettinger, Melissa L. Johnson et al. · Journal of Clinical Oncology · 2017 · 415 citations · Full text